Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serko Limited Director's Dealing 2022

Jun 2, 2022

66271_rns_2022-06-02_0926ad3f-bb06-4557-ba3b-281efac4ab6b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [96 x 26] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listed issuer: Serko Limited(SKO)
Date this disclosure made: 2-Jun-22
Date of last disclosure: 23-Aug-21
Director or senior managergiving disclosure
Full name(s): Darrin Grafton
Name of listed issuer: Serko Limited(SKO)
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
OrdinaryShares in Serko Limited
Class of affected quoted financial products: OrdinaryShares in Serko Limited
Nature of the affected relevant interest(s): 1. Legal owner of unlisted options to
acquire ordinary shares in the form of
Restricted Share Units.
2. Indirect interest in Restricted Share
Units acquired through a personal
relationship with the legal holder.
Any shares granted upon vesting of
these relevant interests are subject to
a deed restricting the exercise of any
voting rights attached. The Restricted
Share Units have no voting rights
attached.
For that relevant interest-
Number held in class before acquisition or disposal: 1. 68,897 Restricted Share Units
2. 1,614 Restricted Share Units
Number held in class after acquisition or disposal: 1. 134,217 Restricted Share Units
2. 3,044 Restricted Share Units
Currentregisteredholder(s): N/A
Registered holder(s) once transfers are registered: 1. Darrin Grafton
2. Donna Bailey
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlyingfinancialproducts:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any):
N/A
A statement as to whether the derivative is cash settled orphysicallysettled:
N/A
N/A
N/A
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any):
N/A
A statement as to whether the derivative is cash settled orphysicallysettled: N/A
Maturitydate of the derivative(if any): N/A
Expirydate of the derivative(if any): N/A
Theprice specified in the terms of the derivative(if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevantinterestinthe derivative:
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevantinterestinthe derivative:
N/A

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates:

2

Details of transactions requiring disclosure-

Date of transaction: 30-May-22 (Grant Date)
Nature of transaction: Grant of unlisted Restricted Share
Units under Serko Long Term
Incentive Scheme 2018.
Name of anyotherpartyorparties to the transaction(if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value,describe the consideration:
Services to Serko. Non-cash
consideration valued at $4.61 per
Restricted Share Unit.
Number of financialproducts to which the transaction related: 1. 65,320 Restricted Share Units
2. 1,430 Restricted Share Units
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod: N/A
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
N/A
Date of the prior written clearance (if any): N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:

Ordinary Shares in Serko Limited 1. Registered holder and beneficial owner of Ordinary Shares 2. Registered holder and beneficial owner of Ordinary Shares By virtue of a personal relationship: 3. Indirect interest in Ordinary Shares 4. Indirect interest in Ordinary Shares 1. 10,867,629 Ordinary Shares 2. 186,123 Ordinary Shares 3. 1,217,594 Ordinary Shares 4. 12,305 Ordinary Shares 1. Darrin Grafton and Geoffrey Hosking for Grafton Howe #2 Trust 2. Darrin Grafton 3. Donna Bailey Trust 4. Donna Bailey N/A

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price's specified terms (if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
N/A
For that derivative relevant interest,-
Parties to the derivative: N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

N/A

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

2-Jun-22